High-sensitivity C-reactive protein concentration in a healthy Brazilian population

International Journal of Cardiology

Volumn 97, Issue 3, 2004, Pages 433-438

  Araújo, Fernando ^a   Pereira, Alexandre C ^a   Latorre, Maria Do Rosário D O ^a   Krieger, José E ^a   Mansur, Alfredo J ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

C reactive protein; Epidemiology; Risk factors

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; BRAZIL; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORRELATION COEFFICIENT; FEMALE; GENDER; HEART DISEASE; HEART RATE; HUMAN; LABORATORY TEST; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY ANALYSIS; SMOKING; STRATIFICATION; TIME SERIES ANALYSIS;

ADOLESCENT; ADULT; AGED; AGING; BIOLOGICAL MARKERS; BODY MASS INDEX; BRAZIL; C-REACTIVE PROTEIN; FEMALE; HUMANS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED;

EID: 9244247301     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2003.10.027     Document Type: Article

References (36)

1. Rifai N., Ridker P.M. High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin. Chem. 47:2001;403-411
2. Ridker P.M. High-sensitivity C-reactive protein. Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation. 103:2001;1813-1818
3. Wener M.H., Daum P.R., McQuillan G.M. The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration. J. Rheumatol. 27:2000;2351-2359
4. Chenillot O., Henny J., Steinmetz J., Herbeth B., Wagner C., Siest G. High sensitivity C-reactive protein: biological variations and reference limits. Clin. Chem. Lab. Med. 38:2000;1003-1011
5. Wong N.D., Pio J., Valencia R., Thakal G. Distribution of C-reactive protein and its relation to risk factors and coronary heart disease risk estimation in the National Health and Nutrition Examination Survey (NHANES) III. Prev. Cardiol. 4:2001;109-114
6. Yamada S., Gotoh T., Nakashima Y., Kayaba K., Ishikawa S., Nago N., et al. Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population: Jichi Medic School Cohort Study. Am. J. Epidemiol. 153:2001;1183-1190
7. McConnell J.P., Branum E.L., Ballman K.V., Lagerstedt S.A., Katzmann J.A., Jaffe A.S. Gender differences in C-reactive protein concentrations- confirmation with two sensitive methods. Clin. Chem. Lab. Med. 40:2002;56-59
8. Pieroni L., Bastard J.P., Piton A., Khalil L., Hainque B., Jardel C. Interpretation of circulating C-reactive protein levels in adults: body mass index and gender are a must. Diabetes Metab. 29:2003;133-138
9. Saito M., Ishimitsu T., Minami J., Ono H., Ohrui M., Matsuoka H. Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors. Atherosclerosis. 167:2003;73-79
10. Ford E.S., Giles W.H., Myers G.L., Rifai N., Ridker P.M., Mannino D.M. C-reactive protein concentration distribution among US children and young adults: findings from the National Health and Nutrition Examination Survey, 1999-2000. Clin. Chem. 49:2003;1353-1357
11. Kuller L.H., Tracy R.P., Shaten J., Meilahn E.N. Relation of C-reactive protein and coronary heart disease in the MRFIT. Nested case-control study. Am. J. Epidemiol. 144:1996;537-547
12. Mendall M.A., Patel P., Ballam L., Strachan D.P., Northfield T.C. C-reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ. 312:1996;1061-1065
13. Tracy R.P., Psaty B.M., Macy E., Bovill E.G., Cushman M., Cornell E.S., et al. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler. Thromb. Vasc. Biol. 17:1997;2167-2176
14. Rohde L.E.P., Hennekens C.H., Ridker P.M. Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men. Am. J. Cardiol. 84:1999;1018-1022
15. Mendall M.A., Strachan D.P., Butland B.K., Ballam L., Morris J., Sweetnam P.M., et al. C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. Eur. Heart J. 21:2000;1584-1590
16. Bermudez E.A., Rifai N., Buring J.E., Manson J.E., Ridker P.M. Relation between markers of systemic vascular inflammation and smoking in women. Am. J. Cardiol. 89:2002;1117-1119
17. Bermudez E.A., Rifai N., Buring J., Manson J.E., Ridker P.M. Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler. Thromb. Vasc. Biol. 22:2002;1668-1673
18. Bazzano L.A., He J., Muntner P., Vupputuri S., Whelton P.K. Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann. Intern. Med. 138:2003;891-897
19. Koenig W., Sund M., Fröelich M., Fischer H.G., Löwel H., Döring A., et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsberg Cohort Study, 1984 to 1992. Circulation. 99:1999;237-242
20. Tracy R.P., Lemaitre R.N., Psaty M.B., Ives D.G., Evans R.W., Cushman M., et al. Relation of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the cardiovascular health study and the rural health promotion project. Arterioscler. Thromb. Vasc. Biol. 17:1997;1121-1127
21. Strandberg T.E., Tilvis R.S. C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly. Arterioscler. Thromb. Vasc. Biol. 20:2000;1057-1060
22. Visser M., Bouter L., McQuillan G., Wener M., Harris T.B. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 282:1999;2131-2135
23. Hak A.E., Stehouwer C.D.A., Bots M.L., Polderman K.H., Schalkwijk C.G., Westendorp I.C.D., et al. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler. Thromb. Vasc. Biol. 19:1999;1986-1991
24. Barinas-Mitchell E., Cushman M., Meilahn E., Tracy R.P., Kuller L.H. Serum levels of C-reactive protein are associated with obesity, weight gain, and hormone replacement therapy in healthy postmenopausal women. Am. J. Epidemiol. 153:2001;1094-1101
25. Tchernof A., Nolan A., Sites C.K., Ades P.A., Pochlman E.T. Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation. 105:2002;564-569
26. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 336:1997;973-979
27. Danesh J., Whincup P., Walker M., Lennon L., Thomson A., Appleby P., et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ. 321:2000;199-204
28. Ridker P.M., Hennekens C.H., Buring J.E., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 342:2000;836-843
29. Ridker P.M., Glynn R.J., Hennekens C.H. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation. 97:1998;2007-2011
30. Moraes R.S., Fuchs F.D., Beltrami Moreira L., Wiehe M., Martins Pereira G., Costa Fuchs S. Risk factors for cardiovascular disease in a Brazilian population-based cohort study. Int. J. Cardiol. 90:2003;205-211
31. Ockene I.S., Matthews C.E., Rifai N., Ridker P.M., Reed G., Stanek E. Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin. Chem. 47:2001;444-450
32. Hager K., Machein U., Krieger S., Platt D., Seefried G., Bauer J. Interleukin-6 and selected plasma proteins in healthy persons of different ages. Neurobiol. Aging. 15:1994;2007-2011
33. Yudkin J.S., Kumari M., Humphries S.E., Mohamed-ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis. 148:2000;209-214
34. Ridker P.M., Rifai N., Rose L., Buring J.E., Cook N. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N. Engl. J. Med. 347:2002;1557-1565
35. Ridker P.M., Hennekens C.H., Rifai N., Buring J.E., Manson J.E. Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation. 100:1999;713-716
36. Frohlich M., Muhlberger N., Hanke H., Imhof A., Doring A., Pepys M.B., et al. Markers of inflammation in women on different hormone replacement therapies. Ann. Med. 35:2003;353-361